⌘K
Loading ticker…
As of 2026-08-24, Clene Inc. Common Stock (CLNN) has a 3-month relative strength percentile of 12 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 39. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 8.6%, relative volume 0.46×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
CLNN is in a stage 4 downtrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -18.4% / -26.2%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
CLNN is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $991K notional.
Held by 2 ETFs · $1M across latest filings · largest weight 0.00% (VXF).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $991K | — |
| VXFVanguard Extended Market ETF | 0.00% | $493K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CLNN Jan avg: 18.45% median: 18.78% win: 50% σ: 48.43% n: 4 2022-04-12 → 2026-07-31 | CLNN Feb avg: -2.05% median: -8.71% win: 50% σ: 21.67% n: 4 2022-04-12 → 2026-07-31 | CLNN Mar avg: -10.45% median: -7.98% win: 25% σ: 15.60% n: 4 2022-04-12 → 2026-07-31 | CLNN Apr avg: -2.22% median: -3.57% win: 40% σ: 17.26% n: 5 2022-04-12 → 2026-07-31 | CLNN May avg: -4.72% median: 2.13% win: 60% σ: 14.21% n: 5 2022-04-12 → 2026-07-31 | CLNN Jun avg: 6.19% median: 8.27% win: 60% σ: 13.73% n: 5 2022-04-12 → 2026-07-31 | CLNN Jul avg: -8.60% median: -11.81% win: 20% σ: 25.46% n: 5 2022-04-12 → 2026-07-31 | CLNN Aug avg: 11.81% median: 4.30% win: 50% σ: 28.33% n: 4 2022-04-12 → 2026-07-31 (current) | CLNN Sep avg: -9.04% median: -9.15% win: 25% σ: 18.37% n: 4 2022-04-12 → 2026-07-31 | CLNN Oct avg: 14.95% median: 8.49% win: 50% σ: 74.74% n: 4 2022-04-12 → 2026-07-31 | CLNN Nov avg: -7.98% median: -5.03% win: 50% σ: 21.66% n: 4 2022-04-12 → 2026-07-31 | CLNN Dec avg: -13.56% median: -18.97% win: 25% σ: 31.35% n: 4 2022-04-12 → 2026-07-31 |